Clinical Trial Details
Braintumor Website

[Information provided by:, which provides patients, family members, and members of the public easy and free access to information on clinical studies for a wide range of diseases and conditions.]

NCT02775136 : An Evaluation of a Non-invasive Brain Monitor
AgesMin: 18 Years Max: N/A
Inclusion Criteria:

1. Adult men and women subjects, aged 18 years old and over at screening visit

2. Subjects with neuropathology that the principal investigator considers including in
this study.

3. Survival expectancy greater than 72 hours

4. Subject or legal authorized representative (per local regulation) is able and willing
to comply with the requirements of the protocol

5. Subject or legal authorized representative (per local regulation) is able to
understand and sign written informed consent to participate in the study

Exclusion Criteria:

1. Local ear infection

2. Known allergy or hypersensitivity to any of the test materials or contraindication to
test materials

3. For women of childbearing potential: pregnancy (positive pregnancy test) or

4. Subjects currently enrolled in or less than 30 days post-participation in other
investigational device or drug study(s), or receiving other investigational agent(s)

5. Any condition that may jeopardize study participation (e.g., abnormal clinical or
laboratory finding) or interpretation of study results, or may impede the ability to
obtain informed consent (e.g., mental condition)
LinksPermanent Link to THIS page:      |      Link to official listing

Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2020 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557